Everolimus 0.25mg

What Is Everolimus 0.25mg

Everolimus 0.25mg is a specialized medicine used in cancer treatment and in some cases after organ transplant. It works on the body’s immune system and cell growth process. Because of this, it must be used under the guidance of an oncologist (cancer specialist) or a transplant specialist.

This medicine belongs to a group called mTOR inhibitors (medicines that slow down cell growth and division). In certain diseases, especially cancer, cells grow very fast and out of control. Everolimus helps slow down this abnormal growth.

It is also used in patients who have received an organ transplant. In such cases, the immune system may attack the new organ. Everolimus helps control the immune response (body’s defense system) so the transplanted organ can function properly.

This is a low-strength dose (0.25mg) and is usually part of a carefully planned treatment. Doctors adjust the dose based on the condition, response, and patient safety.

Uses of Everolimus 0.25mg

Everolimus 0.25mg is used in different medical conditions where controlling cell growth or immune activity is important.

It is commonly prescribed for:

Certain types of cancer, such as:

Breast cancer

Kidney cancer

Neuroendocrine tumors (tumors that develop in hormone-producing cells)

Organ transplant patients, to prevent organ rejection (when the body attacks the new organ)

Tuberous sclerosis complex (TSC), a condition that causes non-cancerous tumors in different parts of the body

In cancer treatment, this medicine helps:

Slow down tumor growth

Reduce the spread of cancer cells

In transplant care, it helps:

Protect the transplanted organ

Maintain long-term organ function

The effect may take time, so regular use and monitoring are important.

How Everolimus 0.25mg Works

Everolimus 0.25mg works by blocking a specific pathway in the body called the mTOR pathway (a system that controls cell growth and survival).

In many diseases, this pathway becomes overactive. This leads to:

Rapid cell growth

Increased survival of abnormal cells

Everolimus blocks this pathway and slows down these processes.

As a result:

Cancer cells grow more slowly

Abnormal cells stop multiplying

Immune activity is reduced in transplant patients

This helps control disease progression and improves treatment outcomes.

In simple terms, Everolimus slows down the signals that tell cells to grow and multiply, which helps manage serious conditions.

Side Effects of Everolimus 0.25mg

Because Everolimus 0.25mg affects the immune system and cell growth, side effects can occur. Some are mild, while others need attention.

Common side effects:

Mouth ulcers (painful sores inside the mouth)

Weakness or tiredness

Loss of appetite

Diarrhea

Skin rash

Some people may also experience:

Infections (due to reduced immunity)

Swelling in hands or feet

High blood sugar levels

Serious side effects may include:

Lung problems (shortness of breath or cough)

Kidney issues

Increased risk of infections

Delayed wound healing

If you notice fever, breathing difficulty, or unusual symptoms, contact your specialist immediately.

Regular blood tests are often required to monitor your condition during treatment.

Safety & Precautions

Everolimus 0.25mg should be taken exactly as prescribed by an oncologist (cancer specialist) or transplant specialist.

Do not change the dose or stop the medicine on your own. This medicine needs careful monitoring.

Before starting treatment, inform your specialist if you have:

Liver or kidney disease

Diabetes (high blood sugar)

Any ongoing infection

Avoid contact with people who have infections, as your immunity may be low.

Do not take vaccines without medical advice, especially live vaccines.

Avoid grapefruit or grapefruit juice, as it may affect how the medicine works in your body.

If you are pregnant or planning pregnancy, discuss risks with your specialist. This medicine may harm the unborn baby.

Maintain good oral hygiene to reduce the risk of mouth ulcers.

Medical Disclaimer

This content is for educational purposes only. It does not replace medical advice, diagnosis, or treatment. Always consult a qualified oncologist (cancer specialist) or an appropriate medical specialist before using Everolimus 0.25mg or any medicine. Do not start or stop any medication without proper guidance.